Therefore, pathological conditions associated with tumor proliferation, tumor cell turnover, and tissue damage, are thought to be more likely to increase AST than ALT, thus making the AST/ALT ratio an attractive potential biomarker [55]. This evidence concerns the gene GPT and neoplasm.